Target intelligence / Profile preview

Adenosine receptor (AR) (AR)

Target
AR
Molecular classification
G protein-coupled receptor, Purinergic receptor, P1 receptor family
01

Overview

Adenosine receptors are a class of G protein-coupled receptors (GPCRs) that mediate the physiological effects of extracellular adenosine, a nucleoside that acts as a cytoprotective modulator in response to cellular stress [1, 3]. The family consists of four distinct subtypes—A1, A2A, A2B, and A3—which are classified based on their primary signaling pathways: A1 and A3 typically inhibit adenylyl cyclase via Gi proteins, while A2A and A2B stimulate it via Gs proteins [6, 15]. These receptors are widely expressed throughout the body and regulate critical processes such as heart rate, neurotransmitter release, sleep-wake cycles, and immune cell function [5, 11]. In pathological states, adenosine receptors are key players in neurodegeneration, cardiovascular disorders, and the immunosuppressive environment of tumors [2, 9]. Therapeutic targeting of adenosine receptors involves both agonists and antagonists, depending on the desired clinical outcome [3, 6]. For instance, A2A antagonists like istradefylline are used to treat motor symptoms in Parkinson's disease, while A2A agonists like regadenoson are employed in cardiac stress testing [7, 11]. In oncology, blocking A2A and A2B receptors is a promising strategy to enhance anti-tumor immunity by preventing adenosine from suppressing T-cell activity [10, 17]. However, the ubiquitous distribution of these receptors presents significant challenges, as drugs must achieve high selectivity to avoid systemic side effects such as hypotension or respiratory distress [5, 9].

Other names
P1 purinoceptorP1 receptorAdenosine A1 receptor (ADORA1)Adenosine A2A receptor (ADORA2A)Adenosine A2B receptor (ADORA2B)Adenosine A3 receptor (ADORA3)
02

Mechanism of action

Adenosine receptors are G protein-coupled receptors that modulate intracellular cyclic AMP levels through coupling with Gi (A1, A3) or Gs (A2A, A2B) proteins. Drugs targeting these receptors act as agonists or antagonists to modulate downstream signaling pathways involved in neurotransmission, cardiovascular function, and immune regulation [1, 3, 6].

03

Biological functions

Signal transductionNeuromodulationVasodilationImmune responseCell protectionSleep regulationHeart rate regulationAngiogenesis
04

Disease associations

Parkinson's diseaseCancerAsthmaCardiovascular diseaseNeurodegenerative diseaseInflammationGlaucomaDiabetesChronic pain
05

Safety considerations

Cardiovascular side effects (e.g., bradycardia, tachycardia, hypotension)BronchoconstrictionCentral nervous system effects (e.g., insomnia, anxiety)Species-specific differences in ligand affinityOff-target effects due to ubiquitous expression
06

Interacting drugs

Adenosine

10 more in the full profile.

07

Biomarkers

AdenoSig (gene expression signature)CD73 expressionA2A receptor density (PET imaging)Platelet A2A receptor levels

Beyond the preview

Go deeper on Adenosine receptor (AR) (AR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adenosine receptor (AR) (AR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call